Recurrent Bordetella holmesii bacteremia and nasal carriage in a patient receiving rituximab

Emerg Infect Dis. 2013 Oct;19(10):1703-5. doi: 10.3201/eid1910.130345.
No abstract available

Keywords: Bordetella holmesii; bacteria; cellulitis; pneumonia; respiratory infections; rituximab.

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage*
  • Antineoplastic Agents / administration & dosage*
  • Bacteremia / diagnosis*
  • Bacteremia / drug therapy
  • Bacteremia / prevention & control
  • Bordetella / isolation & purification*
  • Bordetella Infections / diagnosis*
  • Bordetella Infections / drug therapy
  • Bordetella Infections / prevention & control
  • Carrier State
  • Cellulitis / diagnosis
  • Cellulitis / drug therapy
  • Cellulitis / microbiology
  • Drug Resistance, Bacterial
  • Drug Therapy, Combination
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Maintenance Chemotherapy
  • Male
  • Nose / microbiology*
  • Recurrence
  • Rituximab
  • Treatment Failure

Substances

  • Anti-Bacterial Agents
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab